ESTERO, FL AND NEW YORK, NY / / June 24, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug delivery technology, today ...

Universal presumption of low-dose aspirin, instead of risk-based screenings, can increase uptake for preeclampsia prevention ...

Changing the prescribing protocol for low-dose aspirin (LDA) for preeclampsia prevention from risk-based to universal significantly increased aspirin use in pregnant patients, based on new data ...

For decades, taking low-dose aspirin every day was widely recommended as an easy way to prevent heart attacks and strokes. But that advice has changed.

Low-dose aspirin therapy is often used for pain relief, but it can also help prevent heart attack and stroke. Learn about the benefits of an aspirin regimen for heart health, the risks of taking ...

NCX4016 is a novel nitric oxide-releasing derivative of aspirin that was synthesized to overcome gastrointestinal issues linked to aspirin. Although low doses of NCX4016 have been found to be as ...

Use of daily low-dose aspirin for 3 years didn't prevent age-related macular degeneration (AMD) in older adults, according to a secondary analysis of the randomized ASPREE trial.

Older adults who take low-dose aspirin on a daily basis may be prone to an increased risk of brain bleeds, according to a new study. While aspirin appeared to reduce the occurrence of ...

In a recent study, researchers found that low dose aspirin did not significantly reduce stroke risk in older adults, but increased the risk of intracranial bleeding or brain hemorrhage by 38%.

In a trial of more than 16,000 people over 70, those who took a low-dose of aspirin every day were just under 10 per cent more likely to have a fall that required hospital care than those on placebo ...